Pharmaceutical Exporter from India to Saudi Arabia
Indian Generic Medicines (IGM) is a WHO-GMP-aligned, DGFT-registered pharmaceutical exporter from India to Saudi Arabia — supplying generic and branded medicines, oncology, antibiotics, antivirals, cardiac and neurology drugs and vaccines to buyers across the Kingdom, with full SFDA-ready documentation.
India to Saudi Arabia: a leading pharmaceutical supply corridor
India is one of the largest suppliers and exporters of medicines to Saudi Arabia. India’s pharmaceutical exports reached approximately USD 30.5 billion in FY25, and shipments to the West Asia–North Africa region grew from around USD 1.32 billion (FY21) to USD 1.75 billion (FY25), with Saudi Arabia among the most reliant markets (Pharmexcil). Trade-data platforms track 20+ Indian finished formulations flowing into the Kingdom of Saudi Arabia (KSA) — including targeted oncology and specialty drugs such as sorafenib, everolimus and esomeprazole.
Medicines are supplied as tablets, capsules, injectables and combination products from facilities holding WHO-GMP, US FDA and EU-GMP certifications. As a reliable pharmaceutical exporter from India to Saudi Arabia, IGM operates within this corridor with full SFDA-ready documentation.
Key takeaways
- Saudi Arabia has the largest pharmaceutical market in the GCC (approximately USD 8–11 billion) and still imports around 70% of its medicines — creating sustained demand for reliable Indian suppliers.
- Every medicinal product must be registered with the Saudi Food and Drug Authority (SFDA) and imported through a licensed local agent before it can be sold in the KSA.
- A trusted WHO-GMP pharmaceutical exporter provides a full document set: COA, CPP (COPP), GMP certificate, MSDS and Certificate of Origin.
- The SFDA may waive on-site GMP inspection where the site is already approved under the GCC-DR framework, US FDA or EMA, with reliance pathways that can shorten timelines.
- IGM is a DGFT-registered pharma export company supplying generics, branded, oncology, antibiotics, antivirals, cardiac/neurology drugs and vaccines.
Why Saudi Arabia relies on Indian pharmaceutical exports
A growing population and the Vision 2030 modernisation agenda have driven rising demand for high-quality, affordable medicines. India’s manufacturing ecosystem — decades deep, backed by internationally recognised certifications and anchored by the world’s largest generic-medicines industry — makes an Indian pharmaceutical exporter to Saudi Arabia both cost-effective and dependable. Four factors explain why the KSA consistently turns to India:
What a pharmaceutical exporter from India to Saudi Arabia supplies
The range spans virtually every therapeutic segment Saudi hospitals, distributors and pharmacy chains require:
Indian Generic Medicines: a trusted export partner for the KSA
Saudi buyers look for three non-negotiables — a proven track record, verifiable certifications and reliable supply capacity. IGM is built to deliver all three:
How to import medicine from India to Saudi Arabia — step by step
Who in Saudi Arabia should work with an Indian exporter
What Saudi Arabia requires from Indian exporters
The SFDA is an ICH member rated at WHO Maturity Level 4 — among the most stringent regulators in MENA. Medicines must be registered in the national drug registry (submitted via the Saudi Drug Registration system in eCTD format through a licensed local agent) or imported under a specific authorization; approval is typically a five-year registration subject to renewal and pricing review. WHO-GMP is the international benchmark the SFDA uses to verify a foreign facility’s quality credentials.
| Document | Purpose |
|---|---|
| Certificate of Analysis (COA) | Confirms quality and composition of each batch. |
| Certificate of Pharmaceutical Product (CPP/COPP) | Confirms the product’s regulatory status/approval in India. |
| GMP Certificate | Confirms the site meets Good Manufacturing Practice standards. |
| Material Safety Data Sheet (MSDS) | Required for certain product categories. |
| Certificate of Origin | Confirms manufacture in India. |
| Packing List & Commercial Invoice | Required for customs clearance. |
DGFT registration is fundamental for any legitimate Indian exporter — providing authentic documentation and accountability across the supply chain. The SFDA also requires a substantial remaining shelf life at import and mandates Arabic-language labelling for consumer-facing products; IGM coordinates with manufacturing partners so products meet KSA-specific shelf-life and labelling rules before shipment.
Source certified medicines from India for Saudi Arabia
Request a product catalogue, price and quotation. Share your therapeutic list, quantities and labelling needs — we’ll respond with SFDA-ready documentation and logistics options.
Frequently asked questions
Several Indian exporters serve the Saudi market, including Ikris Pharma Network, The Indian Pharma (TIP) and Indian Generic Medicines (IGM). These are DGFT-registered exporters with Middle East experience, working with EU-GMP/US-FDA manufacturing partners and SFDA-aligned documentation for buyers across Riyadh, Jeddah and Dammam.
A DGFT-registered exporter working with WHO-GMP/GMP-certified partners, able to provide COA, CPP (COPP), GMP certificate, MSDS and Certificate of Origin for every order, and familiar with SFDA registration. IGM meets these across generics, branded, oncology, hematology and vaccines.
At minimum DGFT registration and WHO-GMP/EU-GMP-certified manufacturing, with COA, CPP (COPP), GMP certificate, MSDS and Certificate of Origin per shipment. ISO 9001 is a strong quality indicator, and the exporter should understand SFDA registration.
By sea and air freight depending on product type and timeline. Temperature-sensitive products such as vaccines and certain biologics ship by air with validated cold-chain packaging and temperature monitoring throughout transit.
Yes. With the right certifications and documentation, Indian exporters can support MOH and NUPCO tenders through Saudi-based authorised representatives. IGM’s product range, documentation readiness and bulk capacity suit tender-scale procurement.
Generics across major therapeutic categories, oncology drugs, antibiotics and anti-infectives, HIV/antiviral and hepatitis treatments, cardiac and neurology formulations, and cold-chain vaccines. Request a full catalogue by contacting IGM.
Sea freight to Jeddah Islamic Port or Dammam typically takes about 10–18 days, subject to shipping line and port congestion; air freight to Riyadh, Jeddah or Dammam takes roughly 4–5 days. Customs clearance depends on documentation completeness and SFDA registration status.
Yes. The SFDA requires Arabic labelling on consumer-facing products, and IGM coordinates with manufacturing partners to ensure compliant Arabic labelling. Share labelling requirements at the initial inquiry.
Because of India’s cost-competitive generic manufacturing, WHO-GMP-certified facilities and broad product portfolio. Around 70% of Saudi medicines are still imported, and India’s quality-plus-affordability combination makes it a natural source.
Typically WHO-GMP certification, EU-GMP or US FDA approval where applicable, CTD/eCTD dossier preparation for registration, and ICH-guideline compliance — all aligning with SFDA expectations.
Your trusted medicine exporter from India to Saudi Arabia
Saudi Arabia runs one of the largest, most demanding and best-regulated pharmaceutical markets in the Middle East. Serving it well takes an Indian partner that combines certified manufacturing quality, full documentation capability, a broad product range and a genuine grasp of the SFDA environment — the standard IGM is built to meet. As a DGFT-registered pharmaceutical exporter from India to Saudi Arabia, IGM supplies WHO-GMP-aligned medicines, oncology drugs, antibiotics, HIV and hepatitis treatments, vaccines, injectables, APIs and surgical products to buyers across Riyadh, Jeddah, Dammam, Al Khobar, Makkah, Madinah and every region of the Kingdom — each order backed by complete SFDA-compatible documentation and reliable logistics.
